EPL
OLMA icon

EDBI Pte Ltd’s Olema Pharmaceuticals OLMA Stock Holding History

EDBI Pte Ltd’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,181
Closed -$9K – 23
2022
Q3 		$9K Hold
3,181
– – 0.01% 26
2022
Q2 		$13K Hold
3,181
– – 0.01% 25
2022
Q1 		$14K Hold
3,181
– – 0.01% 22
2021
Q4 		$30K Buy
+3,181
New +$65.9K 0.02% 19

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EDBI Pte Ltd's OLMA Position: Q4 2022 in Review

EDBI Pte Ltd sold out of Olema Pharmaceuticals (OLMA) in Q4 2022, closing a stake of 3,181 shares — an estimated $9K sold.

EDBI Pte Ltd first reported a position in OLMA in Q4 2021 and held it in 4 quarters. The position peaked at $30K in Q4 2021. 66 funds tracked by Wall St. Rank hold OLMA as of Q4 2022.

  • EDBI Pte Ltd reported no remaining Olema Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • EDBI Pte Ltd sold 3,181 Olema Pharmaceuticals shares in Q4 2022, an estimated $9K.
  • EDBI Pte Ltd first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • EDBI Pte Ltd's Olema Pharmaceuticals position peaked at $30K in Q4 2021.
  • 66 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2022.

Based on EDBI Pte Ltd's 13F filing for Q4 2022, filed 30 Jan 2023.